Theoretical Vaccine Effectiveness for Novavax Unacceptably Low
Theoretical Vaccine Effectiveness for Novavax Unacceptably Low
Real World Study Disappointing for Non-Genetic Vaccine
By Peter A. McCullough, MD, MPH
If it came to forced COVID-19 vaccination against human will, I have said Novavax would be the choice since it gives a limited 5 mcg dose of the potentially lethal Spike protein and has no genetic material. The growing number of fatal side effects with mRNA vaccines and recent news of contamination with SV-40 cDNA has resulted in record low rates of booster uptake, currently at 1.3% of unwary Americans.
Mateo-Urdiales reported on 20,903 individuals who took the two shot primary series of Novavax. Theoretical vaccine effectiveness was shockingly low:
“Adjusted estimated vaccine effectiveness against notified SARS-CoV infections in those with partial vaccination (15 days after the first dose to 14 days after the second dose) was 23%(95%CI, 13%-33%), increasing after full vaccination to 31% (95%CI, 22%-39%). Estimated vaccine effectiveness was higher against symptomatic COVID-19, with an estimate of 31% (95%CI, 16%-44%) in those partially vaccinated and of 50% (95%CI, 40%-58%) in those fully vaccinated.”
If a vaccine cannot safely provide at least 50% protection for a year, it is not viable in my clinical practice. Sadly Novavax failed at both of these outcomes. With low-risk Omicron, and likely substantial natural immunity by Fall of 2022, only 26 infections led to hospitalization during the study period; 1 occurred during the reference period, 7 during partial vaccination, and 18 after full vaccination. No deaths were reported.
In summary, Novavax is probably the safest of all the COVID-19 vaccines because it does not use genetic technology. Sadly, it is useless against Omicron and cannot be recommended for any health benefit.
Please subscribe to Courageous Discourse as a paying or founder member so we can continue to bring you the truth.
Peter A. McCullough, MD, MPH
President, McCullough Foundation
Sounds like Novavax shot is just as effective against SARS-CoV-2 infection as the flu shot is against the flu.
I'm grateful to Novavax for being late to market. That made it possible to tell my doctor "I'm waiting for Novavax" in order to put off the mRNA jabs. Now that mRNA is such an obvious, catastrophic failure, it's easier to just refuse any COVID shot or any mRNA potion.